See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2014_Assertio_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 337,045,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 82,521,000 |
| 2 | PropertyPlantAndEquipmentNet | 8,340,000 |
| 3 | remainder_Assets | 80,747,000 |
| 4 | LiabilitiesCurrent | 156,857,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 105,176,000 |
| 9 | ResearchAndDevelopmentExpense | 8,073,000 |
| 10 | remainder_Expenses | -27,094,000 |
| 11 | remainder_Revenues | 134,205,000 |
| 12 | remainder_NetIncome | -4,737,000 |
| 13 | remainder_ComprehensiveNetIncome | -38,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 508,653,000 |
| 1 | Liabilities | 156,857,000 |
| 2 | Expenses | 86,155,000 |
| 3 | Revenues | 134,205,000 |
| 4 | StockholdersEquity | 351,796,000 |
| 5 | NetIncome | 43,313,000 |
| 6 | ComprehensiveNetIncome | 43,294,000 |
| 7 | BaseVar | 445,322,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.43 |
| 9 | EconomicCapitalRatio | 3.31 |
Edgar->Model Mapping
Feature Distribution
Change over Time
